Literature DB >> 23122229

A novel luminescent biosensor for rapid monitoring of IP3 by split-luciferase complementary assay.

Farangis Ataei1, Masoud Torkzadeh-Mahani, Saman Hosseinkhani.   

Abstract

Inositol 1,4,5-trisphosphate (IP(3)) is a crucial second messenger that regulates complicated signaling processes in various physiological events. Alteration in its content has been observed in many diseases. Hence, development of a high-throughput screening system to monitor temporal changes of IP(3) is essential for screening of new potential therapeutic compounds. Toward a simple, sensitive and rapid method for measuring IP(3), we describe the development and application of a novel biosensor based on luciferase fragment assisted complementation strategy, which converts the ligand-induced conformational changes to light. Designed sensor comprising the IP(3)-binding core domain of IP(3)-receptor fused between complementary non-functional fragments of firefly luciferase allows direct detection of IP(3) in presence of luciferin substrate both in cell lysate and in living cells. According to the result presented in this manuscript, the screening time was very fast and maximum response was obtained up to 11-fold higher than untreated cells. Moreover, the designed biosensor was able to monitor release of IP(3) upon induction by different inducers like Bradykinin and ATP. The current biosensor not only provides a specific IP(3) detector in vitro but also facilitates monitoring of the response of IP(3) in living organisms.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23122229     DOI: 10.1016/j.bios.2012.09.037

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  9 in total

1.  Illuminating G-Protein-Coupling Selectivity of GPCRs.

Authors:  Asuka Inoue; Francesco Raimondi; Francois Marie Ngako Kadji; Gurdeep Singh; Takayuki Kishi; Akiharu Uwamizu; Yuki Ono; Yuji Shinjo; Satoru Ishida; Nadia Arang; Kouki Kawakami; J Silvio Gutkind; Junken Aoki; Robert B Russell
Journal:  Cell       Date:  2019-05-31       Impact factor: 41.582

2.  Quantitative Determination and Imaging of Gαq Signaling in Live Cells via Split-Luciferase Complementation.

Authors:  Timo Littmann; Takeaki Ozawa; Günther Bernhardt
Journal:  Methods Mol Biol       Date:  2021

3.  Inhibition of noncaspase proteases, calpain and proteasome, via ALLN and Bortezomib contributes to cell death through low degradation of pro-/anti-apoptotic proteins and apoptosis induction.

Authors:  Roghaye Hamidi; Farangis Ataei; Saman Hosseinkhani
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

Review 4.  Interrogating Cellular Communication in Cancer with Genetically Encoded Imaging Reporters.

Authors:  Seth T Gammon; Tracy W Liu; David Piwnica-Worms
Journal:  Radiol Imaging Cancer       Date:  2020-07-31

5.  Analysis of Protein-Protein Interactions by Split Luciferase Complementation Assay.

Authors:  Yuekun Lang; Zhong Li; Hongmin Li
Journal:  Curr Protoc Toxicol       Date:  2019-12

Review 6.  Luciferase fragment complementation imaging in preclinical cancer studies.

Authors:  Madryn C Lake; Eric O Aboagye
Journal:  Oncoscience       Date:  2014-06-01

7.  A split luciferase-based probe for quantitative proximal determination of Gαq signalling in live cells.

Authors:  Timo Littmann; Takeaki Ozawa; Carsten Hoffmann; Armin Buschauer; Günther Bernhardt
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

8.  Effects of Linker Flexibility and Conformational Changes of IP3 Receptor on Split Luciferase Complementation Assay.

Authors:  Maryam Moradi; Saman Hosseinkhani; Seyed Shahriar Arab; Anahita Khammari
Journal:  Iran J Biotechnol       Date:  2020-10-01       Impact factor: 1.671

9.  SpyTag/SpyCatcher Cyclization Enhances the Thermostability of Firefly Luciferase.

Authors:  Meng Si; Qing Xu; Ling Jiang; He Huang
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.